• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 28 of 100
A woman in Bangladesh receiving a COVID-19 vaccine
Health
On the hunt for a ‘universal’ COVID-19 vaccine as Delta variant surges
By Jeremy KahnAugust 18, 2021
The politics behind President Biden’s plan to lower prescription drug prices
Politics
The politics behind President Biden’s plan to lower prescription drug prices
By Geoff ColvinAugust 14, 2021
Pharmacies face extra audit burdens that threaten their existence
Health
Pharmacies face extra audit burdens that threaten their existence
By Markian Hawryluk and Kaiser Health NewsAugust 6, 2021
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
Finance
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
By Robert Langreth and BloombergAugust 3, 2021
Image of a predicted protein structure rom the malaria parasite
Health
In giant leap for biology, DeepMind’s A.I. reveals secret building blocks of human life
By Jeremy KahnJuly 22, 2021
A picture of a protein shape.
Tech
DeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By Jeremy KahnJuly 15, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Newsletters
The never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Health
Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By Sy MukherjeeJuly 8, 2021
Cures for many rare diseases might already exist. Why aren’t we using them?
Commentary
Cures for many rare diseases might already exist. Why aren’t we using them?
By Annette BakkerJuly 5, 2021
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
Health
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
By Suzi Ring and BloombergJuly 2, 2021
States step up push to regulate pharmacy drug brokers
Health
States step up push to regulate pharmacy drug brokers
By Katheryn Houghton and Kaiser Health NewsJune 30, 2021
Want cheaper insulin? Try Walmart
Want cheaper insulin? Try Walmart
By Marco Quiroz-GutierrezJune 29, 2021
Intellia CRISPR gene editing stock science
Health
We can now edit genes inside the body. That sent this biotech’s stock soaring
By Sy MukherjeeJune 28, 2021
COVID Delta Delta plus variants
Newsletters
The delta between the Delta variants
By Sy MukherjeeJune 24, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
1...
  • 26
  • 27
  • 28
  • 29
  • 30
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.